Drug Discovery World

JULY 11, 2023

In addition, the vast complexity of human disease often means we need a better understanding of all the variables involved in a specific process. These different fundamental approaches (rules-based versus pattern recognition) to building these systems provide multiple opportunities to interject them into disease diagnostics and treatments.

Science 100

Science Drugs FDA Engineering 100

Agency IQ

OCTOBER 12, 2023

Joneckis said that CBER has “some limited uses that we have seen in external submissions, mostly in the bioinformatics area,” but not as many as CDER. Regarding artificial intelligence (AI), an important topic at RAPS Convergence, the two centers discussed external and internal use cases.

FDA 40

FDA Clinical Trials International Drugs 40

Broad Institute

JULY 10, 2023

Credit: Allison Colorado, Broad Communications Arriving in the Bay Area after a childhood in increasingly diverse surroundings, Martin became acutely aware of health disparities and the profound differences in disease prevalence among different populations. I wanted to know how I could have any impact on studying genetic diversity.”

Bioinformatics 98

Bioinformatics Disease Medical Schools Research 98

Drug Discovery World

NOVEMBER 15, 2022

It has made its way into almost every aspect of drug discovery, whether it’s exploring basic biology, modelling diseases, identifying and validating targets, or performing drug screens. . A story-teller at heart, Ramanathan also delivers science communication workshops. . . . . .

DNA 246

DNA Engineering Drugs Vaccine 246